Login
Streaming News
Register
Menu
Subscribe
Podcast
Streaming News
Most Active
About Us
List Of OTC Companies
OTC Pink
OTCQB
OTCQX
Close Menu
Visit Website
HOW TO USE DISCUSSION BOARDS
Office Hours: 9:00 AM - 4:00 PM (EST) Monday - Thursday Call:
602-821-1102
Featured News
MSCLF
Satellos Bioscience Announces Q2 2023 Financial Results and Operational Highlights
Satellos Bioscience Receives Orphan Drug Designation from the U.S. FDA for SAT-3153, a First-in-Class Small Molecule Therapeutic for Duchenne Muscular Dystrophy
Satellos Bioscience to Present at Annual MDA Clinical and Scientific Conference and Insights in Research Investor Summit
Satellos Bioscience Announces Further Preclinical Progress with SAT-3153 As a Potential Treatment for Duchenne Muscular Dystrophy
MSCLF
Quote
|
News
|
Filings
|
Discuss
0
Discussion
MSCLF
Login
-or-
Register
to join the discussion.
X
Search
Generic filters
Hidden label
Hidden label
Hidden label
Hidden label